Jacob Bergstedt

Jacob Bergstedt

Auto-generated profile, based on publicly available information

Jacob Bergstedt

Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TCThe Milieu Intérieur Consortium
The Milieu Intérieur Consortium
EPEtienne Patin
Etienne Patin
MHMilena Hasan
Milena Hasan
JBJacob Bergstedt
Jacob Bergstedt
VRVincent Rouilly
Vincent Rouilly
MAMatthew L. Albert
Matthew L. Albert

13 September 2019 in Microbiome
Verified
Journal Article
Open access
PDF file
TCThe Milieu Intérieur Consortium
The Milieu Intérieur Consortium
PSPetar Scepanovic
Petar Scepanovic
FHFlavia Hodel
Flavia Hodel
SMStanislas Mondot
Stanislas Mondot
VPValentin Partula
Valentin Partula
JFJacques Fellay
Jacques Fellay
Background: The gut microbiome is an important determinant of human health. Its composition has been shown to be influenced by multiple environmental factors and likely by host genetic variation. In the framework of the Milieu Intérieur Consortium, a total of 1000 healthy individuals of western European ancestry, with a 1:1 sex ratio and evenly stratified across five decades of life (age 20–69), were recruited. We generated 16S ribosomal RNA profiles from stool samples for 858 participants. We investigated genetic and non-genetic factors that contribute to individual differences in fecal microbiome composition. Results: Among 110 demographic, clinical, and environmental factors, 11 were identified as significantly correlated with α-diversity, ß-diversity, or abundance of specific microbial communities in multivariable models. Age and blood alanine aminotransferase levels showed the strongest associations with microbiome diversity. In total, all non-genetic factors explained 16.4% of the variance. We then searched for associations between > 5 million single nucleotide polymorphisms and the same indicators of fecal microbiome diversity, including the significant non-genetic factors as covariates. No genome-wide significant associations were identified after correction for multiple testing. A small fraction of previously reported associations between human genetic variants and specific taxa could be replicated in our cohort, while no replication was observed for any of the diversity metrics. Conclusion: In a well-characterized cohort of healthy individuals, we identified several non-genetic variables associated with fecal microbiome diversity. In contrast, host genetics only had a negligible influence. Demographic and environmental factors are thus the main contributors to fecal microbiome composition in healthy individuals. Trial registration: ClinicalTrials.gov identifier NCT01699893

17 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
RARudi Agius
Rudi Agius
CBChristian Brieghel
Christian Brieghel
MAMichael A. Andersen
Michael A. Andersen
APAlexander T. Pearson
Alexander T. Pearson
BLBruno Ledergerber
Bruno Ledergerber
CNCarsten U. Niemann
Carsten U. Niemann
Infections have become the major cause of morbidity and mortality among patients with chronic lymphocytic leukemia (CLL) due to immune dysfunction and cytotoxic CLL treatment. Yet, predictive models for infection are missing. In this work, we develop the CLL Treatment-Infection Model (CLL-TIM) that identifies patients at risk of infection or CLL treatment within 2 years of diagnosis as validated on both internal and external cohorts. CLL-TIM is an ensemble algorithm composed of 28 machine learning algorithms based on data from 4,149 patients with CLL. The model is capable of dealing with heterogeneous data, including the high rates of missing data to be expected in the real-world setting, with a precision of 72% and a recall of 75%. To address concerns regarding the use of complex machine learning algorithms in the clinic, for each patient with CLL, CLL-TIM provides explainable predictions through uncertainty estimates and personalized risk factors.

6 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JBJacob Bergstedt
Jacob Bergstedt
SASadoune Ait Kaci Azzou
Sadoune Ait Kaci Azzou
KTKristin Tsuo
Kristin Tsuo
AJAnthony Jaquaniello
Anthony Jaquaniello
AUAlejandra Urrutia
Alejandra Urrutia
LQLluís Quintana-Murci
Lluís Quintana-Murci
Epigenetic changes are required for normal development, yet the nature and respective contribution of factors that drive epigenetic variation in humans remain to be fully characterized. Here, we assessed how the blood DNA methylome of 884 adults is affected by DNA sequence variation, age, sex and 139 factors relating to life habits and immunity. Furthermore, we investigated whether these effects are mediated or not by changes in cellular composition, measured by deep immunophenotyping. We show that DNA methylation differs substantially between naïve and memory T cells, supporting the need for adjustment on these cell-types. By doing so, we find that latent cytomegalovirus infection drives DNA methylation variation and provide further support that the increased dispersion of DNA methylation with aging is due to epigenetic drift. Finally, our results indicate that cellular composition and DNA sequence variation are the strongest predictors of DNA methylation, highlighting critical factors for medical epigenomics studies.

11 November 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ABAllyson L. Byrd
Allyson L. Byrd
MLMenghan Liu
Menghan Liu
KFKei E. Fujimura
Kei E. Fujimura
SLSvetlana Lyalina
Svetlana Lyalina
DNDeepti R. Nagarkar
Deepti R. Nagarkar
TCthe Milieu Intérieur Consortium
the Milieu Intérieur Consortium
As microbial therapeutics are increasingly being tested in diverse patient populations, it is essential to understand the host and environmental factors influencing the microbiome. Through analysis of 1,359 gut microbiome samples from 946 healthy donors of the Milieu Intérieur cohort, we detail how microbiome composition is associated with host factors, lifestyle parameters, and disease states. Using a genome-based taxonomy, we found biological sex was the strongest driver of community composition. Additionally, bacterial populations shift across decades of life (age 20–69), with Bacteroidota species consistently increased with age while Actinobacteriota species, including Bifidobacterium, decreased. Longitudinal sampling revealed that short-term stability exceeds interindividual differences. By accounting for these factors, we defined global shifts in the microbiomes of patients with non-gastrointestinal tumors compared with healthy donors. Together, these results demonstrated that the microbiome displays predictable variations as a function of sex, age, and disease state. These variations must be considered when designing microbiome-targeted therapies or interpreting differences thought to be linked to pathophysiology or therapeutic response.

17 June 2024 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
JBJacob Bergstedt
Jacob Bergstedt
JPJoëlle A. Pasman
Joëlle A. Pasman
ZMZiyan Ma
Ziyan Ma
AHArvid Harder
Arvid Harder
SYShuyang Yao
Shuyang Yao
FFFang Fang
Fang Fang
Major depressive disorder (MDD) and cardiovascular disease (CVD) are often comorbid, resulting in excess morbidity and mortality. Here we show that CVDs share most of their genetic risk factors with MDD. Multivariate genome-wide association analysis of shared genetic liability between MDD and atherosclerotic CVD revealed seven loci and distinct patterns of tissue and brain cell-type enrichments, suggesting the involvement of the thalamus. Part of the genetic overlap was explained by shared inflammatory, metabolic and psychosocial or lifestyle risk factors. Our data indicated causal effects of genetic liability to MDD on CVD risk, but not from most CVDs to MDD, and showed that the causal effects were partly explained by metabolic and psychosocial or lifestyle factors. The distinct signature of MDD–atherosclerotic CVD comorbidity suggests an immunometabolic subtype of MDD that is more strongly associated with CVD than overall MDD. In summary, we identified biological mechanisms underlying MDD–CVD comorbidity and modifiable risk factors for prevention of CVD in individuals with MDD.